We are live on ! Find out more
FC

Fairpointe Capital Portfolio holdings

AUM $66.3M
1-Year Est. Return 101.32%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+101.32%
3 Year Est. Return
+48.06%
5 Year Est. Return
+95.29%
10 Year Est. Return
AUM
$3B
AUM Growth
+$96.3M
Cap. Flow
-$321M
Cap. Flow %
-10.7%
Top 10 Hldgs %
32.14%
Holding
86
New
2
Increased
20
Reduced
36
Closed
5

Top Sells

Rank Stock Value
1
NYT icon
New York Times
NYT
+$44.3M
2
TDC icon
Teradata
TDC
+$40.7M
3
VAR
Varian Medical Systems, Inc.
VAR
+$37.7M
4
GGB icon
Gerdau
GGB
+$36.7M
5
WOLF icon
Wolfspeed
WOLF
+$31.1M

Sector Composition

Rank Sector Weight
1 Industrials 20.45%
2 Consumer Discretionary 18.66%
3 Technology 15.24%
4 Communication Services 14.09%
5 Consumer Staples 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWA icon
51
BorgWarner
BWA
$12.8B
$2.06M 0.07%
60,867
-532,626
-90% -$18.4M
CLAR icon
52
Clarus
CLAR
$125M
$1.42M 0.05%
111,337
UNF icon
53
Unifirst Corp
UNF
$5.45B
$1.36M 0.05%
8,892
+4,000
+82% +$562K
HYPD
54
Hyperion DeFi Inc
HYPD
$35.5M
$1.07M 0.04%
2,244
LBY
55
DELISTED
Libbey, Inc.
LBY
$1.03M 0.03%
361,193
+50,000
+16% +$214K
GILD icon
56
Gilead Sciences
GILD
$165B
$975K 0.03%
15,000
SANW
57
DELISTED
S&W Seed Co
SANW
$957K 0.03%
18,792
AIOT
58
PowerFleet Inc
AIOT
$537M
$886K 0.03%
149,488
LAB icon
59
Standard BioTools
LAB
$342M
$864K 0.03%
65,000
BC icon
60
Brunswick
BC
$5.23B
$755K 0.03%
15,000
LIND icon
61
Lindblad Expeditions
LIND
$1.95B
$685K 0.02%
44,924
BREW
62
DELISTED
Craft Brew Alliance, Inc.
BREW
$545K 0.02%
38,987
GE icon
63
GE Aerospace
GE
$364B
$504K 0.02%
10,132
-906
-8% -$42.7K
NLSN
64
DELISTED
Nielsen Holdings plc
NLSN
$473K 0.02%
20,000
IBM icon
65
IBM
IBM
$213B
$452K 0.02%
3,347
-157
-4% -$20K
FLL icon
66
Full House Resorts
FLL
$83.4M
$451K 0.02%
223,232
AUD
67
DELISTED
Audacy, Inc.
AUD
$425K 0.01%
80,895
QCOM icon
68
Qualcomm
QCOM
$164B
$376K 0.01%
6,590
+1,200
+22% +$64.8K
BMY icon
69
Bristol-Myers Squibb
BMY
$129B
$310K 0.01%
6,490
+400
+7% +$19.9K
MBII
70
DELISTED
Marrone Bio Innovations, Inc.
MBII
$292K 0.01%
191,000
+58,760
+44% +$89.7K
A icon
71
Agilent Technologies
A
$39.6B
$273K 0.01%
3,400
+200
+6% +$15.2K
JPM.PRG
72
DELISTED
JPMorgan Chase & Co. Depositary Shares, each representing a 1/400th interest in a share of 6.10% Non
JPM.PRG
$262K 0.01%
10,000
RMD icon
73
ResMed
RMD
$31.1B
$209K 0.01%
+2,010
New +$207K
PWR icon
74
Quanta Services
PWR
$84.2B
$204K 0.01%
+5,400
New +$189K
DF
75
DELISTED
Dean Foods Company
DF
$204K 0.01%
67,300

Similar funds

Fairpointe Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Fairpointe Capital held 86 positions worth $3B, up 3.3% from $2.91B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Fairpointe Capital withdrew a net $321M in Q1 2019, closing 5 positions and reducing 36 holdings. Its most notable exit was Gerdau, an estimated $36.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Fairpointe Capital opened a new position in ResMed worth $209K.

  • Fairpointe Capital's largest Q1 2019 buy was ResMed: 2,010 shares worth $209K.
  • Fairpointe Capital added most to Magna International in Q1 2019, an estimated $49.2M increase.
  • Fairpointe Capital's biggest Q1 2019 reduction was New York Times, cutting an estimated $44.3M.
  • Fairpointe Capital fully exited Gerdau in Q1 2019, selling an estimated $36.7M.
  • Fairpointe Capital's ten largest holdings make up 32% of its $3B portfolio in Q1 2019.
  • Fairpointe Capital opened 2 new positions and closed 5 in Q1 2019.
  • Fairpointe Capital's portfolio value rose 3.3% quarter-over-quarter to $3B.

Based on Fairpointe Capital's 13F filing for Q1 2019, filed 14 May 2019.